TREATMENT OF ADVANCED BREAST-CANCER WITH CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL AND PREDNISONE (CMFP)

被引：0
|
作者：
RABINOVICH, MG
LEONE, BA
LANDO, O
机构：
来源：
MEDICINA-BUENOS AIRES | 1981年 / 41卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：65 / 70
页数：6
相关论文
共 50 条
  • [21] ESTROGEN-RECEPTORS AND RESPONSE TO CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN ADVANCED BREAST-CANCER
    CHANG, JC
    HILL, GW
    WERGORSKI, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 411 - 411
  • [22] ACTIVITY OF ADRIAMYCIN IN METASTATIC BREAST-CANCER RESISTANT TO A COMBINATION REGIMEN WITH CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL, VINCRISTINE, AND PREDNISONE
    FREDERIKSEN, PL
    JOERGENSEN, ST
    ROESDAHL, K
    THOMSEN, J
    MOURIDSEN, HT
    CANCER TREATMENT REPORTS, 1978, 62 (03): : 449 - 450
  • [23] CYTOXAN, 5-FLUOROURACIL, AND PREDNISONE (CFP) AND IMMUNOTHERAPY IN ADVANCED BREAST-CANCER
    BRITELL, JC
    BISEL, H
    AHMANN, DL
    FRYTAK, S
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 396 - 396
  • [24] A RANDOMIZED TRIAL OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE VERSUS CYCLOPHOSPHAMIDE, 5-FLUOROURACIL, AND PREDNISONE IN PATIENTS WITH METASTATIC BREAST-CANCER
    AHMANN, DL
    SCHAID, DJ
    INGLE, JN
    BISEL, HF
    SCHUTT, AJ
    BUCKNER, JC
    LONG, HJ
    RUBIN, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (03): : 179 - 183
  • [25] A TRIAL OF VINCRISTINE (V), ADRIAMYCIN (A) AND CYCLOPHOSPHAMIDE (C) VERSUS CYCLOPHOSPHAMIDE (C), METHOTREXATE (M), 5-FLUOROURACIL (F) AND PREDNISONE (P) IN ADVANCED BREAST-CANCER
    CARMOPEREIRA, J
    COSTA, FO
    HENRIQUES, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 439 - 439
  • [26] COMBINATION CHEMOTHERAPY WITH CMF (CYCLOPHOSPHAMIDE, METHOTREXATE, 5-FLUOROURACIL) VERSUS CNF (MITOXANTRONE, 5-FLUOROURACIL, CYCLOPHOSPHAMIDE) IN ADVANCED BREAST-CANCER - A MULTICENTER RANDOMIZED STUDY
    LORUSSO, V
    VICI, P
    BIANCO, AR
    LOPEZ, M
    DEPLACIDO, S
    PIANO, A
    PALOMBA, G
    CARLOMAGNO, C
    DAPRILE, M
    FOSSER, V
    BRANDI, M
    DELENA, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1993, 2 (04) : 531 - 535
  • [27] ADRIAMYCIN, VINCRISTIN, CYCLOPHOSPHAMIDE AND 5-FLUOROURACIL (AVCF) ADJUVANT TREATMENT OF BREAST-CANCER COMPARED TO TREATMENT WITH CYCLOPHOPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF)
    MATHE, G
    MISSET, JL
    PLAGNE, R
    BELPOMME, D
    LEMEVEL, B
    GUERRIN, J
    FUMOLEAU, P
    METZ, R
    DELGADO, M
    DEVASSAL, F
    ERIGUCHI, M
    SCHNEIDER, M
    REIZENSTEIN, P
    BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 168 - 168
  • [28] ADRIAMYCIN, CYCLOPHOSPHAMIDE, AND 5-FLUOROURACIL IN TREATMENT OF METASTASIZING BREAST-CANCER
    HOFFKEN, K
    SEEBER, S
    BOECKER, WR
    SCHMIDT, CG
    ZEITSCHRIFT FUR KREBSFORSCHUNG UND KLINISCHE ONKOLOGIE, 1976, 86 (02): : 135 - 145
  • [29] VARIABILITY IN THE PHARMACOKINETICS OF CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL IN WOMEN RECEIVING ADJUVANT TREATMENT FOR BREAST-CANCER
    MOORE, MJ
    ERLICHMAN, C
    THIESSEN, JJ
    BUNTING, PS
    HARDY, R
    KERR, I
    SOLDIN, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 (06) : 472 - 476
  • [30] ON THE SAFETY OF PERIOPERATIVE ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL IN BREAST-CANCER
    RUDENSTAM, CM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (08): : 1305 - 1308
12345